Suppr超能文献

一种用于评估非 ST 段抬高型心肌梗死患者临床结局的新风险评分系统。

A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction.

机构信息

Chonnam National University Hospital, South Korea.

出版信息

Int J Cardiol. 2010 Dec 3;145(3):450-4. doi: 10.1016/j.ijcard.2009.06.001. Epub 2009 Jun 21.

Abstract

BACKGROUND AND OBJECTIVES

Prediction for long-term clinical outcomes in patients with non-ST elevation acute coronary syndrome is important as well as early risk stratification. The aim of this study is to develop a simple assessment tool for better early bedside risk stratification for both short- and long-term clinical outcomes.

SUBJECTS AND METHODS

2148 patients with non-ST-segment elevation myocardial infarction (NSTEMI) (64.9±12.2 years, 35.0% females) were enrolled in a nationwide prospective Korea Acute Myocardial Infarction Registry (KAMIR). A new risk score was constructed using the variables related to one year mortality: TIMI risk index (17.5-30: 1 point, >30: 2 points), Killip class (II: 1 point, >II: 2 points) and serum creatinine (≥1.5 mg/dL: 1 point), based on the multivariate-adjusted risk relationship. The new risk score system was compared with the Global Registry of Acute Coronary Events (GRACE) and TIMI risk scores during a 12-month clinical follow-up.

RESULTS

During a one year follow-up, all causes of death occurred in 362 patients (14.3%), and 184 (8.6%) patients died in the hospital. The new risk score showed good predictive value for one year mortality. The accuracy for in-hospital and one year post-discharge mortality rates, the new risk score demonstrated significant differences in predictive accuracy when compared with TIMI and GRACE risk scores.

CONCLUSION

A new risk score in the present study provides simplicity with accuracy simultaneously for early risk stratification, and also could be a powerful predictive tool for long-term prognosis in NSTEMI.

摘要

背景与目的

预测非 ST 段抬高型急性冠状动脉综合征患者的长期临床结局非常重要,同时也需要进行早期风险分层。本研究旨在开发一种简单的评估工具,以便更好地进行早期床边短期和长期临床结局的风险分层。

对象与方法

本研究共纳入了 2148 名非 ST 段抬高型心肌梗死(NSTEMI)患者(64.9±12.2 岁,35.0%为女性),这些患者均来自于全国范围内前瞻性的韩国急性心肌梗死注册研究(KAMIR)。使用与一年死亡率相关的变量(TIMI 风险指数[17.5-30 分:1 分,>30 分:2 分]、Killip 分级[II 级:1 分,>II 级:2 分]和血清肌酐[≥1.5mg/dL:1 分])构建了一个新的风险评分。根据多变量调整后的风险关系,对新的风险评分系统进行了构建。并在 12 个月的临床随访期间,将其与全球急性冠状动脉事件注册(GRACE)和 TIMI 风险评分进行了比较。

结果

在一年的随访期间,共有 362 名患者(14.3%)发生了各种原因导致的死亡,其中 184 名(8.6%)患者在医院内死亡。新的风险评分对于一年死亡率具有良好的预测价值。新的风险评分在预测住院和一年后出院死亡率方面的准确性与 TIMI 和 GRACE 风险评分相比,具有显著差异。

结论

本研究中的新风险评分既简单又准确,可以同时进行早期风险分层,并且也可能是 NSTEMI 患者长期预后的有力预测工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验